Subscribe
A worldwide window to Cambridge business, innovation and technology
TRIMTECH raises $31m from Cambridge UK and US backers

TRIMTECH raises $31m from Cambridge UK and US backers

Cambridge biotech TRIMTECH Therapeutics, which is harnessing targeted protein degradation for the treatment of neurodegenerative diseases, has closed an oversubscribed $31 million (£25m) seed round featuring a number of US investors.
Cambridge Innovation Capital to curate Start Codon future

Cambridge Innovation Capital to curate Start Codon future

For DeepTech funder Cambridge Innovation Capital, it’s a case of back to the future after its decision to take venture builder Start Codon under its management.
US funders lead $6.9m Seed round for AI drug pioneer Ignota Labs

US funders lead $6.9m Seed round for AI drug pioneer Ignota Labs

Ignota Labs, an AI-driven drug turnaround company which recently moved to Cambridge Science Park, has closed a $6.9 million seed funding round, co-led by Montage Ventures and AIX Ventures in the US with participation from Modi Ventures, Blue Wire Capital and Gaingels.
Bicycle Therapeutics set for ‘transformational’ 2025, says CEO

Bicycle Therapeutics set for ‘transformational’ 2025, says CEO

Bicycle Therapeutics, Cambridge’s Nasdaq-quoted pharmaceutical business, is on the cusp of what CEO Kevin Lee calls a transformational year. But he pledges there will be no free-wheeling for the Granta Park business despite a robust patent estate.
New £100m Cambridge Innovation Capital fund launched

New £100m Cambridge Innovation Capital fund launched

Cambridge Innovation Capital has launched a new £100 million Opportunity Fund – anchored by Aviva Investors and British Patient Capital – to invest in growing DeepTech and life science companies.
Academia
Sharewatch
Manufacturing
Brain gain milestone as Cambridge Enterprise drives 41 University investments in a year
10 Mar 2025 - 12:00
Cambridge University colleges help fight youth homelessness
06 Mar 2025 - 12:00
Decades of DNA sequencing data from UK child development study released
04 Mar 2025 - 12:00

Business awards

Entries now being accepted

Business directory

Browse our listings of Cambridge companies

The killer 50

The 50 hottest disruptive technology companies

News

42 Technology and partners unveil new AI-powered pharma line clearance solution

42 Technology and partners unveil new AI-powered pharma line clearance solution

42 Technology has joined forces with industry leaders in machine vision, edge AI silicon and software – Balluff, Synaptics and Arcturus Networks – to help develop and demonstrate a breakthrough approach for AI-powered automated line clearance in pharmaceutical manufacturing.
Ori picks Kao Data’s Harlow campus for UK cloud venture

Ori picks Kao Data’s Harlow campus for UK cloud venture

Essex-based Kao Data, a specialist developer and operator of data centres engineered for AI and advanced computing, has been chosen by Ori, the AI-native cloud provider, to host its first, UK-based cloud region.
Brain gain milestone as Cambridge Enterprise drives 41 University investments in a year

Brain gain milestone as Cambridge Enterprise drives 41 University investments in a year

Cambridge Enterprise, the University’s tech transfer arm, powered 41 investments in a milestone 2024 to underline the value of brain power to the Cluster and the UK economy.
Secondmind part of UK’s stellar AI trade mission to Texas

Secondmind part of UK’s stellar AI trade mission to Texas

Cambridge automotive tech trailblazer Secondmind is following in the footsteps of Obama, Gates and Zuckerberg via a UK trade mission to SXSW 2025 in Austin, Texas from March 8-11. The company is one of 14 in the delegation showcasing AI brilliance in the UK.
More news

Tech trail

TRIMTECH raises $31m from Cambridge UK and US backers

TRIMTECH raises $31m from Cambridge UK and US backers

Cambridge biotech TRIMTECH Therapeutics, which is harnessing targeted protein degradation for the treatment of neurodegenerative diseases, has closed an oversubscribed $31 million (£25m) seed round featuring a number of US investors.
Cambridge Innovation Capital to curate Start Codon future

Cambridge Innovation Capital to curate Start Codon future

For DeepTech funder Cambridge Innovation Capital, it’s a case of back to the future after its decision to take venture builder Start Codon under its management.
US funders lead $6.9m Seed round for AI drug pioneer Ignota Labs

US funders lead $6.9m Seed round for AI drug pioneer Ignota Labs

Ignota Labs, an AI-driven drug turnaround company which recently moved to Cambridge Science Park, has closed a $6.9 million seed funding round, co-led by Montage Ventures and AIX Ventures in the US with participation from Modi Ventures, Blue Wire Capital and Gaingels.
New £100m Cambridge Innovation Capital fund launched

New £100m Cambridge Innovation Capital fund launched

Cambridge Innovation Capital has launched a new £100 million Opportunity Fund – anchored by Aviva Investors and British Patient Capital – to invest in growing DeepTech and life science companies.
More Tech trail

Trade floor

42 Technology and partners unveil new AI-powered pharma line clearance solution

42 Technology and partners unveil new AI-powered pharma line clearance solution

42 Technology has joined forces with industry leaders in machine vision, edge AI silicon and software – Balluff, Synaptics and Arcturus Networks – to help develop and demonstrate a breakthrough approach for AI-powered automated line clearance in pharmaceutical manufacturing.
Sunny future tipped for tanning firm after MBO

Sunny future tipped for tanning firm after MBO

A management team has taken over Power Tan Ltd in Bedfordshire to set the stage for further growth and international expansion for the indoor tanning business.
Cambridge triple role in superfast 5G project

Cambridge triple role in superfast 5G project

Cambridge Consultants and city colleagues at Stratospheric Platforms Ltd and Marshall were in a five-firm consortium honoured for their role in ’Project Skymast’, which aims to deliver superfast 5G to every corner of the globe from the stratosphere.
Nxera Pharma clinches millions from autoimmune disease deal

Nxera Pharma clinches millions from autoimmune disease deal

Nxera Pharma, with major operations in Cambridge and Tokyo, has negotiated a lucrative deal in the autoimmune diseases space in Asia-Pacific.
AVEVA and HMEL sign MOU to drive AI-powered digitalisation in India’s refining sector

AVEVA and HMEL sign MOU to drive AI-powered digitalisation in India’s refining sector

Cambridge headquartered AVEVA, a global leader in industrial software, and HPCL Mittal Energy Limited (HMEL) – a leading Indian integrated refining and petrochemical company – have signed a landmark MOU.
More Trade floor